tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

PSX · Q1 2026 Earnings

Phillips 66

Reported April 6, 2026

30-second summary

SENTIMENT: Mixed Phillips 66 reported Q1 earnings of $207M ($0.51/share reported, $0.49 adjusted on $200M adjusted earnings) alongside a preliminary 8-K guidance update issued before the books closed. The print pairs a structural bull thesis on U.S. refining — "this is the time to be bullish U.S. refining" — with three real concessions: an $839M pre-tax mark-to-market derivative loss, a $3B cash collateral outflow that forced a new $2.25B 364-day term loan, and Q2 chemicals O&P utilization guided down to the low 80s (from a low-90% Q1 actual / mid-90s prior guide). Corporate and other costs ran roughly $90–$130M above the prior $340–$360M Q1 guide and are now guided to $430–$450M as the Q2 run-rate, and a new interim debt waypoint of ~$19B by year-end 2026 has been introduced en route to the unchanged $17B 2027 target. The refining story is genuinely structural; the surrounding cost and working-capital picture is materially worse than the Q4 setup. Note on source documents: the press release is a preliminary 8-K guidance update issued before Q1 FY2026 financial close ("the company has not completed its financial closing procedures for the first quarter"), so segment income and turnaround-expense figures from that document are ranges, not finals. The earnings call disclosed reported and adjusted EPS as point figures.

Guidance

Company raised full-year 2026 debt reduction target to $19B and disclosed new interim path, but Q1 actuals missed on chemicals utilization and costs, with Q2 guidance reflecting persistent weakness in chemicals and elevated corporate spend.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
Global Olefins & Polyolefins utilization rateQ1 FY2026mid-90sLow-90%below guide (mid-90s expected, low-90s delivered)Missed
Refining turnaround expenseQ1 FY2026$125-$145 million$170-$190 million+$25-45M above guideMissed

New guidance

MetricPeriodGuideYoY
Expected debt reduction pathFY 2026approximately $19 billion by year-end 2026
Refining worldwide crude utilization rateQ2 FY2026low to mid-90s
Global Olefins & Polyolefins utilization rateQ2 FY2026low 80s
Refining turnaround expenseQ2 FY2026$120-$150 million
Corporate and other costsQ2 FY2026$430-$450 million

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Corporate and other costs
Q1 FY2026
$340-$360 million$430-$450 million+$70-90M vs. prior guidanceRaised

Reaffirmed unchanged this quarter: Total debt target ($17 billion by year-end 2027)

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
Refining crude utilizationMid-90%
Global Olefins & Polyolefins utilizationLow-90%
Refining turnaround expense$170-$190 million
Mark-to-market derivative losses$900 million pre-tax
Net short derivative position (crude and products)50 million barrels
Liquidity$6 billion
Total debt$27 billion
Net debt$22 billion

Management tone

Q4 FY2024 portfolio defense → Q2 FY2025 post-proxy vindication → Q3 FY2025 capital discipline pivot → Q1 FY2026 opportunity capture

Refining commentary completed its arc from cyclical to structural. Three quarters ago refining was discussed as a "steady drumbeat of improvement"; last quarter as a record-utilization quarter; this quarter management dropped the conditional language entirely with "this is the time to be bullish U.S. refining" and explicitly described U.S. refining as structurally advantaged in a bifurcated global market. The shift is from "we are executing well in a tough cycle" to "the cycle itself has changed shape and we are positioned for it" — and it is being used to justify aggressive commercial posture (Jones Act crude moves, early freight lock-ins) rather than defensive capital preservation.

Mark-to-market losses reframed from balance-sheet pain to managed cash-flow event. Kevin's specific framing — "$3.2 billion out on margin at the end of March. At the end of yesterday, it was $2.1 billion… as volatility subsides, we effectively consume this cash through our normal purchasing activities" — is a notable departure from the typical hedging-loss disclosure pattern, which tends to be apologetic. By quantifying the cash work-down in real time and asserting that capital allocation is not constrained, management is pre-empting the question of whether the $839M income hit or the $3B cash drain derails the deleveraging path.

Debt reduction promoted from priority to dual-track commitment. Q3 FY2025 framed debt as the explicit priority over returns. This quarter, Kevin pushed further: "we can draw that cash down and clearly that will have an offset on debt… all while still returning 50% of our operating cash flow back through dividends and buybacks." The 50% return commitment is now framed as compatible with — not competing against — the new $19B end-2026 interim target. This is a confidence statement about cash generation, not a pivot on capital allocation.

Chemicals tone fractured. Management maintained the bullish CP Chem narrative (tight supply, ethane advantage, world-scale assets forcing out high-cost producers) while simultaneously guiding Q2 O&P utilization down to low 80s. The two signals do not reconcile cleanly. Either the demand softness is being underweighted in the narrative, or the utilization guide is conservative — but the call did not bridge the gap.

Macro hedging language returned for the first time in three quarters. The phrases "volatility likely to persist into next year" and "lasting throughout the rest of this year and into early next year" mark a more cautious outlook posture than Q2 FY2025 or Q3 FY2025, where management leaned into structural tailwinds without time-bounding them. The bull thesis on refining remained intact, but the surrounding macro framing got noticeably more conditional.

Recurring themes management leaned on this quarter:

U.S. energy autonomy and insulation from Middle East disruptionCommercial optionality and margin capture through global logistics arbitrageStructural cost reduction (targeting $5.50/barrel OPEX by 2027)CP Chem margin expansion driven by tight global petrochemical supply and ethane cost advantageRenewable diesel and RIN credit value inflection year-over-yearWestern Gateway pipeline as long-duration growth anchoring midstream to $4.5B EBITDA target

Risks management surfaced:

Unprecedented commodity price volatility exceeding 95th percentile historical movesDuration and persistence of favorable market structure beyond 2026Strait of Hormuz reopening could normalize global refining capacity and compress marginsMiddle East infrastructure recovery timeline creating uncertainty for CP Chem joint venture operationsDemand destruction from elevated product prices, though management claims only 1% observed

Answers to last quarter's watch list

Q1 turnaround expense vs. the $125–$145M Q4-call guide. Q1 FY2026 preliminary turnaround expense came in at $170–$190M. The Q4 FY2025 earnings call transcript guided $125–$145M, but the Q1 8-K's outlook table lists prior guidance as $170–$190M "unchanged" attributed to the Q4 2025 Earnings Presentation. These two prior-guide figures cannot be reconciled from the source documents. Status: Inconclusive pending reconciliation
Midstream Q4 adjusted EBITDA toward the ~$1.125B run-rate. Q1 FY2026 Midstream adjusted income before taxes guided to $550–$600M; the 2027 $4.5B target was reaffirmed.
Continue monitoring
Debt reduction execution against the $1.5B Q4 commitment. Total debt now stands at $27B, with net debt of $22B — debt actually increased in Q1 via the new $2.25B term loan and short-term draws to fund margin calls. A new interim path to ~$19B by year-end 2026 (implying ~$8B of reduction over 2026) was introduced; the multi-year glidepath to $17B by 2027 was reaffirmed and re-anchored.
Continue monitoring
LA refinery wind-down impact on utilization and cost. Worldwide refining utilization printed mid-90% — beating the prior low-90% guide — suggesting LA wind-down did not compress runs. Decommissioning and redevelopment costs are now flowing through Corporate and Other, contributing to the corporate cost overshoot vs the $340–$360M prior guide. Status: Resolved positively on utilization, negatively on cost
M&S U.S. realized fuel margin trajectory off the $2.04/BBL Q3 print. Not separately disclosed; M&S adjusted range of $(150)M–$0M was distorted by MTM and Gulf Coast price-lag effects.
Not resolved
Non-core midstream asset divestiture execution. No concrete divestiture announcement. Three quarters of rhetoric without an announced transaction.
Resolved negatively
Western Gateway pipeline open-season and FID progress. Management cited Western Gateway as a long-duration midstream growth anchor toward the $4.5B 2027 EBITDA target, but no open-season subscription figure or FID date was disclosed.
Continue monitoring

What to watch into next quarter

Whether the $839M income-statement MTM loss recovers toward the ~$500M-by-year-end management trajectory, and whether the $3.2B → $2.1B cash margin work-down continues; a stall on either would compress operating cash flow against the $8B consensus base implied by the new debt path.

Q2 chemicals O&P utilization vs. the low-80s guide — a print below 80% would confirm chemicals demand deterioration is accelerating, not stabilizing, and put the CP Chem bull narrative under pressure.

Whether corporate and other costs hold at $430–$450M or step higher; this is now the structural baseline, and any further drift would compound the Q1 overshoot already absorbed against the $340–$360M prior guide.

Total debt progression from $27B toward the new ~$19B end-2026 waypoint — requires roughly $2B/quarter of net reduction, a pace the company has not historically sustained without asset sales or a significant working-capital release.

Refining turnaround expense vs. the $120–$150M Q2 guide; a meaningful overshoot would establish elevated maintenance as structural rather than period-specific.

Any concrete non-core midstream divestiture announcement — now four quarters of rhetoric without execution; the silence is itself a signal.

Western Gateway open-season subscription level and FID timing — needed to validate the organic Midstream path to $4.5B 2027 EBITDA.

Q2 worldwide market capture vs. the 138% Q1 print — Brian explicitly flagged mid-90s as the right starting point; a print materially above that would suggest the commercial uplift is more durable than management is willing to underwrite.

Sources

  1. Phillips 66 preliminary first-quarter 2026 financial information (8-K/press release), filed with SEC: https://www.sec.gov/Archives/edgar/data/1534701/000153470126000015/psx-2026_q1prexrelease.htm
  2. Phillips 66 Q1 FY2026 earnings conference call — prepared remarks and Q&A (Mark Lazor, Kevin Mitchell, Don Baldrige, Rich Harbison, Brian Mandel).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.